{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:22:24Z","timestamp":1781594544579,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770126"],"award-info":[{"award-number":["81770126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800196"],"award-info":[{"award-number":["81800196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800163"],"award-info":[{"award-number":["81800163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.humimm.2020.05.008","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T07:47:49Z","timestamp":1591775269000},"page":"452-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients"],"prefix":"10.1016","volume":"81","author":[{"given":"Xiaomei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longtian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Hua","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2020.05.008_b0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: New insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2020.05.008_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2020.05.008_b0015","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.178.5.2827","article-title":"IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production","volume":"178","author":"Coquet","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2020.05.008_b0020","first-page":"10259","article-title":"Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals","volume":"88","author":"Williams","year":"2014","journal-title":"J. Virol. Am. Soc. Microbiol. (ASM)"},{"issue":"5","key":"10.1016\/j.humimm.2020.05.008_b0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd4296","article-title":"Interleukin-21: a double-edged sword with therapeutic potential","volume":"13","author":"Spolski","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.humimm.2020.05.008_b0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2020.05.008_b0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2020.05.008_b0040","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.M705100200","article-title":"IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner","volume":"282","author":"Wei","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2020.05.008_b0045","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1182\/blood-2011-10-388546","article-title":"IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis","volume":"119","author":"Attridge","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.05.008_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2014.12.047","article-title":"The role of IL-21 in immunity and cancer","volume":"358","author":"Davis","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.humimm.2020.05.008_b0055","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0802978","article-title":"IL-21 mediates suppressive effects via its induction of IL-10","volume":"182","author":"Spolski","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2020.05.008_b0060","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.bbadis.2017.06.001","article-title":"IL-21\/anti-Tim1\/CD40 ligand promotes B10 activity in vitro and alleviates bone loss in experimental periodontitis in vivo","volume":"1863","author":"Hu","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.humimm.2020.05.008_b0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2013.02.011","article-title":"The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells","volume":"38","author":"Wan","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2020.05.008_b0070","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-Cell lymphoma: a study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.humimm.2020.05.008_b0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.med.59.060906.220345","article-title":"A decade of rituximab: improving survival outcomes in non-Hodgkin\u2019s lymphoma","volume":"59","author":"Molina","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.humimm.2020.05.008_b0080","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.2009.24.5860","article-title":"Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome","volume":"28","author":"Larouche","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.humimm.2020.05.008_b0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood-2009-08-239996","article-title":"Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas","volume":"115","author":"Sarosiek","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.05.008_b0090","doi-asserted-by":"crossref","unstructured":"R. Morita, N. Schmitt, S.-E.E. Bentebibel, R. Ranganathan, L. Bourdery, G. Zurawski et al., Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion, Immunity 34 (2011) 108\u2013121. doi:10.1016\/j.immuni.2010.12.012.","DOI":"10.1016\/j.immuni.2010.12.012"},{"key":"10.1016\/j.humimm.2020.05.008_b0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yexcr.2016.11.017","article-title":"Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway","volume":"350","author":"Cha","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.humimm.2020.05.008_b0100","first-page":"1023","article-title":"Validity of the Ann Arbor staging classification for the non-Hodgkin\u2019s lymphomas","volume":"61","author":"Rosenberg","year":"1977","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.humimm.2020.05.008_b0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.intimp.2018.05.025","article-title":"The prevalence and function of CD4+CXCR5+Foxp3+ follicular regulatory T cells in diffuse large B cell lymphoma","volume":"61","author":"Cha","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2020.05.008_b0110","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1038\/ncomms14647","article-title":"IL-21 restricts T follicular regulatory T cell proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2","volume":"8","author":"Jandl","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2020.05.008_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003362","article-title":"IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection","volume":"9","author":"Schmitz","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.humimm.2020.05.008_b0120","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2020.05.008_b0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.immuni.2011.01.006","article-title":"Blood relatives of follicular helper T cells","volume":"34","author":"Vinuesa","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2020.05.008_b0130","first-page":"e72","article-title":"Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency","volume":"100","author":"Stepensky","year":"2015","journal-title":"Haematol. Ferrata Storti Foundation"},{"key":"10.1016\/j.humimm.2020.05.008_b0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3892\/ol.2014.2062","article-title":"Effect of interleukin 21 and its receptor on CD8+T cells in the pathogenesis of diffuse large B-cell lymphoma","volume":"8","author":"Cha","year":"2014","journal-title":"Oncol. Lett."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920303207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920303207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:53:20Z","timestamp":1777528400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885920303207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0198885920303207"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.05.008","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}